BioSpace News Archive

Business

Xynomic Pharma Achieves Important Regulatory Milestones in China and EU in Potentially Pivotal Kidney Cancer and Lymphoma Trials

Xynomic Pharma and Bison Capital Acquisition Corp. jointly announced that China, Spain and Poland authorities have approved Xynomic’s application to conduct potentially pivotal Phase 3 trial using Xynomic’s abexinostat, in combination with pazopanib, in patients with renal cell carcinoma.

March 16, 2019
·
3 min read
Biotech Bay

Apple Heart Study Demonstrates Ability of Wearable Technology to Detect Atrial Fibrillation

Stanford researchers presented preliminary findings from a virtual study that enrolled more than 400,000 participants.

March 16, 2019
·
4 min read
Job Trends

Clovis Oncology to Highlight Rubraca® (rucaparib) Data from Post-Hoc ARIEL3 Analyses at SGO 2019 Congress

Maintenance treatment with Rubraca significantly improved PFS and reduced the risk of progression vs placebo regardless of whether tumors had deleterious germline BRCA mutations

March 16, 2019
·
14 min read
Drug Development

Edwards SAPIEN 3 Valve Proves Superior To Surgery In Partner 3 Trial

Edwards Lifesciences Corporation announced that the results of the randomized PARTNER 3 Trial demonstrated superiority for the SAPIEN 3 transcatheter aortic valve over outcomes with surgery.

March 16, 2019
·
5 min read
Pharm Country

Novartis late-breaking data further support initiation of Entresto in hospital and as a first-choice systolic heart failure therapy in stabilized patients

Outcomes from PIONEER-HF 4-week open-label extension reinforce initial 8-week findings, showing Entresto® (sacubitril/valsartan) continued to deliver reductions in NT-proBNP, an established biomarker for heart failure severity and prognosis

March 16, 2019
·
21 min read